Did You Suffer Losses in ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky About Securities Fraud ClaimsNewsfile Corp • 03/27/26
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper ResearchGlobeNewsWire • 03/27/26
$ADMA Shareholders: ADMA Biologics Hit with Securities Fraud Investigation After Stock Slides 29% Amid Channel Stuffing Claims – Investors with Losses Alerted to Contact BFA LawGlobeNewsWire • 03/27/26
ADMA BREAKING INVESTIGATION: BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA LawBusiness Wire • 03/26/26
Securities Fraud Investigation Into ADMA Biologics, Inc. (ADMA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 03/26/26
INVESTOR ALERT: Investigation of ADMA Biologics, Inc. (ADMA) Announced by Holzer & Holzer, LLCGlobeNewsWire • 03/26/26
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 03/26/26
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 03/25/26
Securities Fraud Investigation Into ADMA Biologics, Inc. (ADMA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 03/25/26
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against ADMA Biologics, Inc.PRNewsWire • 03/25/26
Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a TurnaroundZacks Investment Research • 03/25/26
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 03/12/26
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase InitiativeGlobeNewsWire • 03/02/26
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv PerformanceZacks Investment Research • 02/26/26
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 02/25/26